Mosaic ImmunoEngineering (CPMV) Shares Issued (2013 - 2021)

Mosaic ImmunoEngineering (CPMV) posted quarterly Shares Issued of $284549.0 for Q3 2021, down 15.32% quarter-over-quarter from $336046.0 in Q2 2021.

Mosaic ImmunoEngineering (CPMV) Shares Issued (2013 - 2021) Analysis & Trends

Mosaic ImmunoEngineering's Shares Issued history runs 5 years deep, the most recent figure standing at $284549.0 for Q3 2021.

In Q3 2021, Shares Issued changed N/A year-over-year to $284549.0; the TTM figure through Sep 2021 stood at $284549.0 (changed N/A YoY), while the FY2020 annual figure was $336328.0, changed N/A from the prior year.
Shares Issued for Q3 2021 stood at $284549.0, down from $336046.0 in the prior quarter.
The five-year high for Shares Issued was $466457.0 in Q1 2021, with the low at $284549.0 in Q3 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Shares Issued (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn	-
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn	-
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn	-
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn	-
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn	-
8	Royalty Pharma	26.98 Bn	26.14 Bn	-	-
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn	-
10	Mosaic ImmunoEngineering	527,536.97	527,536.97	-	-

Download Data